Description
Retatrutide – 10 mg
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors. The glucagon component adds metabolic rate increases on top of appetite suppression.
Common Applications:
- Substantial weight loss (24%+ in trials)
- Metabolic syndrome
- Type 2 diabetes
- Cases where tirzepatide plateaued
Reference Dosing:
Conservative titration: 2 mg/wk x 4 weeks → 4 mg x 4 → 6, 8, up to 12 mg max.

Reviews
There are no reviews yet.